Intrathecal Morphine in Robot-assisted Prostatectomy
RoboITMProst
The Efficacy of Intrathecal Morphine in Patients Undergoing Robot-assisted Prostatectomy
1 other identifier
interventional
30
1 country
1
Brief Summary
This study will investigate the efficacy and safety of intrathecal morphine for the patients undergoing robot-assisted prostatectomy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 18, 2013
CompletedFirst Posted
Study publicly available on registry
November 25, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedJuly 3, 2015
July 1, 2015
7 months
November 18, 2013
July 1, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The evaluation of pain at 24 hours after surgery
The doctor blinded to the investigation will visit patients. The pain will be assessed at rest and at coughing using visual analogue scale.
at postoperatively 24 hours
Secondary Outcomes (3)
The consumption of analgesics
at postoperatively 24 hours
The consumption of intraoperative opioids
From the induction of anesthesia till the emergence of anesthesia, an expected average of 4 hours
The side effects of opioids after surgery
During 72 hours after the end of surgery
Study Arms (2)
The ITM group
EXPERIMENTALThe postoperative pain management includes both the intrathecal morphine injection and the intravenous patient-controlled analgesia.
The IV-PCA group
PLACEBO COMPARATORThe postoperative pain management includes only the intravenous patient-controlled analgesia.
Interventions
The intravenous injection of morphine using the patient-controlled analgesia machine
Eligibility Criteria
You may qualify if:
- Patients scheduled for the open nephrectomy
You may not qualify if:
- Patients with renal insufficiency
- Patients with coagulopathy
- History of any neurologic disorder
- History of recent infection in 2 weeks
- History of drug abuse
- Patients who cannot understand the usage of th intravenous patient-controlled analgesia
- Patients using opioids due to the chronic pain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University of Hospital
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Deok-Man Hong, PhD
Seoul National University of Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
November 18, 2013
First Posted
November 25, 2013
Study Start
November 1, 2013
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
July 3, 2015
Record last verified: 2015-07